TREA

90508673 - MYLUNG CONSORTIUM

Follow

Information

  • Trademark
  • 90508673
  • Serial Number
    90508673
  • Registration Number
    6777452
  • Filing Date
    February 03, 2021
    3 years ago
  • Registration Date
    July 05, 2022
    2 years ago
  • Transaction Date
    July 05, 2022
    2 years ago
  • Status Date
    July 05, 2022
    2 years ago
  • Published for Opposition Date
    April 19, 2022
    2 years ago
  • Location Date
    July 05, 2022
    2 years ago
  • First Use Anywhere Date
    February 04, 2021
    3 years ago
  • First Use In Commerce Date
    February 04, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    QUEEN, ESTHER FELICIA
  • Attorney Name
    Auma N. Reggy
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MYLUNG CONSORTIUM
Case File Statements
  • GS0091: Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures featuring information on research, testing, diagnosis, and treatment for lung cancer
  • PM0001: MY LUNG CONSORTIUM
  • GS0351: Business management, business administration, and office function services in the nature of the facilitation and management of the collection, tracking, and maintenance of data relating to the testing, diagnosis, and treatment of lung cancer from medical providers, patients, medical researchers, and medical, biopharmaceutical, and biotechnology companies; business administration and office function services in the nature of the coordinating the collection, compilation, tracking, and maintenance of information and data relating to the testing, diagnosis, and treatment of lung cancer; Market intelligence services, namely, providing therapeutic insights and benchmarking information to stakeholders in the fields of medicine and healthcare; Promoting collaboration within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Promoting the exchange of information within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Providing information for the development of best practices for the testing, diagnosis, and treatment of lung cancer
  • GS0441: Healthcare services, namely, collection of data and information on research, testing, diagnosis, and treatment of lung cancer for treatment and diagnostic purposes; Providing medical informational services for the purpose of raising awareness, and disseminating best practices for the testing, diagnosis, and treatment of lung cancer
  • D10000: "CONSORTIUM"
  • GS0421: Research services, namely, organizing collaborative research and development of protocols regarding the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing collaboration in medical research and data collection around the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing genomic, medical, biomedical and health care related research regarding lung cancer for medical research purposes; Providing medical research information in the field of lung cancer; Providing medical and scientific research information in the field of lung cancer
Case File Event Statements
  • 7/5/2022 - 2 years ago
    26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 7/5/2022 - 2 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/19/2022 - 2 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/19/2022 - 2 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/30/2022 - 2 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/12/2022 - 2 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/29/2022 - 2 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/28/2022 - 2 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/28/2022 - 2 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/6/2021 - 3 years ago
    17 - NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Type: AAUA
  • 10/5/2021 - 3 years ago
    16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/5/2021 - 3 years ago
    15 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/5/2021 - 3 years ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/5/2021 - 3 years ago
    13 - USE AMENDMENT ACCEPTED Type: IUAA
  • 8/16/2021 - 3 years ago
    12 - AMENDMENT TO USE PROCESSING COMPLETE Type: AUPC
  • 8/16/2021 - 3 years ago
    11 - USE AMENDMENT FILED Type: IUAF
  • 8/15/2021 - 3 years ago
    10 - TEAS AMENDMENT OF USE RECEIVED Type: EAAU
  • 8/12/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/12/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/12/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/19/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/19/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/19/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/14/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/7/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/6/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP